Table 1 Demographic and clinical characteristics of participants
From: Prevalence and risk factors for kidney disease among hospitalized PLWH in China
Total n = 501 | Not on ART n = 204(40.7%) | On ART n = 297(59.3%) | |
|---|---|---|---|
Age, median (IQR), y | 39 (IQR 30–50) | 37 (IQR 28–46) | 40 (IQR 31–52) |
sex, No. (%) | |||
Male | 446(89.0%) | 193(94.6%) | 253(85.2%) |
Female | 55(11.0%) | 11(5.4%) | 44(14.8%) |
BMI, Mean ± SD, kg/m2 | 21.65 ± 3.57 | 21.29 ± 3.59 | 21.91 ± 3.54 |
HBV coinfection, No. (%) | 33(6.6%) | 12(5.9%) | 21(7.1%) |
HCV coinfection, No. (%) | 16(3.2%) | 0(0.0%) | 16(5.4%) |
Syphilis, No. (%) | 139(27.7%) | 58(28.4%) | 81(27.3%) |
Hypertension, No. (%) | 40(8%) | 12(5.9%) | 28(9.4%) |
Diabetes mellitus, No. (%) | 39(7.8%) | 12(5.9%) | 27(9.1%) |
Tumor, No. (%) | 37(7.4%) | 9(4.4%) | 28(9.4%) |
duration of HIV, Median (IQR), mo | 8 (IQR 0–57.5) | 0 (IQR 0–1) | 24 (IQR 6.5–84) |
HIV viral load, median (IQR), copies/mL | 2239 (IQR0–167,717) | 195,721(IQR80916–505,206) | 1(IQR 0–408) |
CD4 count, Median (IQR), cells/uL | 106 (IQR 28.5–362) | 39 (IQR11–149) | 215(IQR 66–458) |
< 200 cells/ uL, No. (%) | 308(61.5%) | 165(80.9%) | 143(48.1%) |
≥ 200 cells/ uL, No. (%) | 198(38.5%) | 39(19.1%) | 154(51.9%) |
Kidney damage, No. (%) | 95(19.0%) | 28(13.7%) | 67(22.6%) |
eGFR, median (IQR), mL/min/1.73 m2 | 115 (103–124) | 116 (105–125) | 105 (76–119) |